Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclin-Dependent Kinase 6 Is a Chromatin-Bound Cofactor for NF-κB-Dependent Gene Expression
Katja Handschick, Knut Beuerlein, Liane Jurida, et al.
Molecular Cell (2014) Vol. 53, Iss. 2, pp. 193-208
Open Access | Times Cited: 136

Showing 26-50 of 136 citing articles:

Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs
Marco De Dominici, Patrizia Porazzi, You‐Cai Xiao, et al.
Blood (2020) Vol. 135, Iss. 18, pp. 1560-1573
Open Access | Times Cited: 67
Role of inflammation in the biology of myeloproliferative neoplasms
Steffen Koschmieder, Nicolas Chatain
Blood Reviews (2020) Vol. 42, pp. 100711-100711
Closed Access | Times Cited: 61
Exosomal miR-21-5p contributes to ovarian cancer progression by regulating CDK6
Jian Cao, Yuan Zhang, Juan Mu, et al.
Human Cell (2021) Vol. 34, Iss. 4, pp. 1185-1196
Closed Access | Times Cited: 51
Therapeutic targeting of replicative immortality
Paul Yaswen, Karen L. MacKenzie, W. Nicol Keith, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S104-S128
Open Access | Times Cited: 64
Progress with palbociclib in breast cancer: latest evidence and clinical considerations
Andrea Rocca, Alessio Schirone, Roberta Maltoni, et al.
Therapeutic Advances in Medical Oncology (2016) Vol. 9, Iss. 2, pp. 83-105
Open Access | Times Cited: 56
CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle
Yao Fan, Haiping Li, Xiaolong Liang, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 19934-19946
Open Access | Times Cited: 50
LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis
Hualong Zhang, Bin Zhao, Xiuxia Wang, et al.
Life Sciences (2019) Vol. 228, pp. 135-144
Closed Access | Times Cited: 44
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis
Anne Müller, Antje Dickmanns, Claudia Resch, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 5765-5781
Open Access | Times Cited: 43
CDK6 Inhibition: A Novel Approach in AML Management
Iris Z. Uras, Veronika Sexl, Karoline Kollmann
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2528-2528
Open Access | Times Cited: 40
Monitoring the Levels of Cellular NF-κB Activation States
Johanna Meier‐Soelch, Christin Mayr‐Buro, J. Unternaehrer Juli, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5351-5351
Open Access | Times Cited: 33
Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications
Mohd Yousuf, Manzar Alam, Anas Shamsi, et al.
International Journal of Biological Macromolecules (2022) Vol. 218, pp. 394-408
Closed Access | Times Cited: 25
Targeting CDK4/6 for Anticancer Therapy
Jiating Qi, Zhuqing Ouyang
Biomedicines (2022) Vol. 10, Iss. 3, pp. 685-685
Open Access | Times Cited: 23
Cyclin‐dependent kinases: Masters of the eukaryotic universe
Aleksandra J. Pluta, Cécilia Studniarek, Shona Murphy, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 14
The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia
Jun Zhang, Lanlan Zhou, Shuai Zhao, et al.
Cell Cycle (2017) Vol. 16, Iss. 12, pp. 1193-1200
Open Access | Times Cited: 46
The Activation of IL-1-Induced Enhancers Depends on TAK1 Kinase Activity and NF-κB p65
Liane Jurida, Johanna Soelch, Marek Bartkuhn, et al.
Cell Reports (2015) Vol. 10, Iss. 5, pp. 726-739
Open Access | Times Cited: 45
K63-Ubiquitylation and TRAF6 Pathways Regulate Mammalian P-Body Formation and mRNA Decapping
Ulas Tenekeci, Michael Poppe, Knut Beuerlein, et al.
Molecular Cell (2016) Vol. 62, Iss. 6, pp. 943-957
Open Access | Times Cited: 45
Efficient DNA binding of NF-κB requires the chaperone-like function of NPM1
Jianhuang Lin, Mitsuyasu Kato, Kyosuke Nagata, et al.
Nucleic Acids Research (2016), pp. gkw1285-gkw1285
Open Access | Times Cited: 43
miR-124-3p is a chronic regulator of gene expression after brain injury
Niina Vuokila, Katarzyna Łukasiuk, Anna Bot, et al.
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 24, pp. 4557-4581
Open Access | Times Cited: 43
The interplay of CDK4 and CDK6 in melanoma
Karoline Kollmann, Coralie Briand, Florian Bellutti, et al.
Oncotarget (2019) Vol. 10, Iss. 14, pp. 1346-1359
Open Access | Times Cited: 42
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review
Kazuto Harada, Yoshifumi Baba, Hironobu Shigaki, et al.
BMC Cancer (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 41
POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling
Zhiyong Shen, Xiaochuang Feng, Yuan Fang, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 11
Open Access | Times Cited: 38
Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR–ABL-Negative Myeloproliferative Neoplasm
Alessandro Allegra, Giovanni Pioggia, Alessandro Tonacci, et al.
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1037-1037
Open Access | Times Cited: 38
CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
Andrew Sulaiman, Sarah McGarry, Xianghui Han, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1128-1128
Open Access | Times Cited: 36
eIF4A Inhibitors Suppress Cell-Cycle Feedback Response and Acquired Resistance to CDK4/6 Inhibition in Cancer
Tim Kong, Yibo Xue, Regina Cencic, et al.
Molecular Cancer Therapeutics (2019) Vol. 18, Iss. 11, pp. 2158-2170
Open Access | Times Cited: 36
Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells
Isabella Maria Mayer, Eszter Doma, Thorsten Klampfl, et al.
Blood (2024) Vol. 144, Iss. 2, pp. 156-170
Open Access | Times Cited: 4

Scroll to top